SEAINT
← Back to SEAINT News

Portfolio Strategy / 2026-11-03

Buy, Build, Operate: Our Software Thesis

Why software acquisitions and products developed in-house belong in the same investment conversation—but should be described differently.

By ALTA / SEAINT Editorial

Two paths to the same responsibility

There are two different ways to become responsible for a software product. One is to acquire an existing business or asset through a negotiated transaction. The other is to identify a problem, assemble the right people and build a new product from the ground up. Both can fit our strategy; neither guarantees an outcome.

Notori represents the acquisition path we have discussed publicly. Initiatives such as SEAINT ONE, TRIST AI and ALMA represent product development work. We believe being specific about those differences is part of communicating responsibly with partners, customers and prospective sellers.

What we look for in software

Our interest is drawn to products that sit close to an essential workflow: answering customers, processing payments, managing jobs, organizing records or turning complex information into decisions. Software with a narrow purpose can be more valuable to its users than a broad platform that tries to do everything.

We also think about the less glamorous questions. Is the code maintainable? Are customers receiving support? What contracts or integration dependencies exist? Can the product grow without losing trust? These operational details determine whether a business has a future beyond its branding.

A portfolio that shares learning

Building and acquiring across several categories gives us a chance to reuse lessons in security, billing, user experience and customer success. It should not mean forcing unrelated products into one system. Each company needs a clear audience and its own operating logic.

The long-term opportunity is a disciplined operating culture: products that are useful on their own, supported by shared judgment and an unwillingness to confuse ambition with completed results.